CA Cancer J Clin. 2025 Jan 22. IF: 503.1Novel clinical trial designs emerging from the molecular reclassification of cancer.www.onlinelibrary.wiley.com/doi/10.3322/caac.21880 JAMA. 2025 Jan 22. IF: 63.1Care for Patients With a History of Immigration.www.jamanetwork.com/journals/jama/fullarticle/2829535 Nature. 2025 Jan 22. IF: 50.5Immune evasion through mitochondrial transfer in the tumour microenvironment.www.nature.com/articles/s41586-024-08439-0 Nature. 2025 Jan 22. IF: 50.5Mitochondrial swap from cancer to immune cells thwarts anti-tumour defences.www.nature.com/articles/d41586-025-00077-4 Nature. 2025 Jan 22. IF: 50.5The new science of menopause: these emerging therapies could change women's health.www.nature.com/articles/d41586-025-00069-4 Nature. 2025 Jan 22. IF: 50.5Menopause research is globally underfunded. It's time to change that.www.nature.com/articles/d41586-025-00150-y J Clin Oncol. 2025 Jan 22. IF: 42.1Lessons From Taxanes Versus Eribulin for First-Line Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the EMERALD Study.www.ascopubs.org/doi/10.1200/JCO-24-02717 Adv Mater. 2025 Jan 22. IF: 27.4An on-Demand Oxygen Nano-vehicle Sensitizing Protein and Nucleic Acid Drug Augment Immunotherapy.www.onlinelibrary.wiley.com/doi/10.1002/adma.202409378 Angew Chem Int Ed Engl. 2025 Jan 22. IF: 16.1Next-Generation Photosensitizers: Cyanine-Carborane Salts for Superior Photodynamic Therapy of Metastatic Cancer.www.onlinelibrary.wiley.com/doi/10.1002/anie.202419759 Nat Commun. 2025 Jan 22;16:932. IF: 14.7Real-world clinical multi-omics analyses reveal bifurcation of ER-independent and ER-dependent drug resistance to CDK4/6 inhibitors.www.nature.com/articles/s41467-025-55914-x Adv Sci (Weinh). 2025 Jan 22. IF: 14.3Improved Efficacy of Triple-Negative Breast Cancer Immunotherapy via Hydrogel-Based Co-Delivery of CAR-T Cells and Mitophagy Agonist.www.onlinelibrary.wiley.com/doi/10.1002/advs.202409835 Adv Sci (Weinh). 2025 Jan 22. IF: 14.3Peptide-Drug Conjugate for Therapeutic Reprogramming of Tumor-Associated Macrophages in Breast Cancer.www.onlinelibrary.wiley.com/doi/10.1002/advs.202410288 Adv Sci (Weinh). 2025 Jan 22. IF: 14.3Therapeutic Black Phosphorus Nanosheets Elicit Neutrophil Response for Enhanced Tumor Suppression.www.onlinelibrary.wiley.com/doi/10.1002/advs.202414779 Cancer Res. 2025 Jan 22. IF: 12.5Comparison of Lean, Obese, and Weight Loss Models Reveals TREM2 Deficiency Attenuates Breast Cancer Growth Uniquely in Lean Mice and Alters Clonal T Cell Populations.www.aacrjournals.org/cancerres/article/751193 Cancer Res. 2025 Jan 22. IF: 12.5SNHG17 Reprograms Energy Metabolism of Breast Cancer by Activating Mitochondrial DNAs Transcription.www.aacrjournals.org/cancerres/article/751176 Cell Rep Med. 2025 Jan 22. IF: 11.7Multimodal integration using a machine learning approach facilitates risk stratification in HR+/HER2- breast cancer.www.cell.com/cell-reports-medicine/fulltext/S2666-3791(24)00695-5 Clin Cancer Res. 2025 Jan 22. IF: 10.0Human Epidermal Growth Factor Receptor 2 Loss Following Treatment with Trastuzumab Deruxtecan in Patients with Metastatic Breast Cancer.www.aacrjournals.org/clincancerres/article/751192 Adv Healthc Mater. 2025 Jan 22. IF: 10.0Bioprinted Fibroblast Mediated Heterogeneous Tumor Microenvironment for Studying Tumor-Stroma Interaction and Drug Screening.www.onlinelibrary.wiley.com/doi/10.1002/adhm.202404642 Cancer Treat Rev. 2025 Jan 13. IF: 9.6Dendritic cells in triple-negative breast cancer: From pathophysiology to therapeutic applications.www.sciencedirect.com/science/article/pii/S0305737225000064 Nano Lett. 2025 Jan 21. IF: 9.6Implantable Microneedles Loaded with Nanoparticles Surface Engineered Escherichia coli for Efficient Eradication of Triple-Negative Breast Cancer Stem Cells.pubs.acs.org/doi/10.1021/acs.nanolett.4c06052 NPJ Precis Oncol. 2025 Jan 22;9(1):22. IF: 6.8Real life outcome analysis of breast cancer brain metastases treated with Trastuzumab Deruxtecan.www.nature.com/articles/s41698-025-00801-3 NPJ Breast Cancer. 2025 Jan 23;11:5. IF: 5.9Triple-negative breast cancer modifies the systemic immune landscape and alters neutrophil functionality.www.nature.com/articles/s41523-025-00721-2
